Response to Treatment with the Leukocyte-derived Immunomodulator IMREG-1 in Immunocompromised Patients with AIDS-related Complex

Marise S. Gottlieb,Robert A. Zackin,Milan Fiala,David H. Henry,Adrien J. Marcel,Kenneth L. Combs,Jeffrey Vieira,Howard A. Liebman,Lawrence A. Cone,Kathryn S. Hillman,A. Arthur Gottlieb

Response to Treatment with the Leukocyte-derived Immunomodulator IMREG-1 in Immunocompromised Patients with AIDS-related Complex

2020

Marise S. Gottlieb
Robert A. Zackin
Milan Fiala
David H. Henry
Adrien J. Marcel
Kenneth L. Combs
Jeffrey Vieira
Howard A. Liebman
Lawrence A. Cone
Kathryn S. Hillman
A. Arthur Gottlieb

▪ Objective: To determine if a 6-month course of therapy with IMREG-1, a leukocyte-derived immunomodulator, slows disease progression in patients with AIDS-related complex. ▪ Design: Randomized, do...

Keywords:

AIDS-related complex
response to treatment
disease progression
Internal medicine
in patient
Diabetes mellitus
Medicine
Cardiology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations